Skip to main content
. 2016 Aug;16(4):371–375. doi: 10.7861/clinmedicine.16-4-371

Fig 1.

Fig 1.

Molecular imaging of dopaminergic dysfunction in Parkinson’s disease. PET and SPECT imaging in a PD patient show reduction of VMAT2 activity, DAT availability, and DDC activity compared with a healthy control. DAT = dopamine transporter; DDC = dopa decarboxylase; PD = Parkinson’s disease; PET = positron emission tomography; SPECT = single-photon emission computed tomography; VMAT2 = type 2 vesicular monoamine transporter. Reproduced with permission from Politis M (2014).1